Skip to main content
. 2019 Mar 18;10(4):957–965. doi: 10.1111/1759-7714.13035

Figure 1.

Figure 1

Flow chart of subject enrollment. PFS, progression‐free survival; PD, progressive disease; TKIs, tyrosine kinase inhibitors.